 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
| |
|||||||||||||||||
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 5, May 2005 Human T-cell Leukemia Virus Type 1 Molecular Variants, Vanuatu, MelanesiaOlivier Cassar,*† Corinne Capuano,‡ Laurent Meertens,† Eliane Chungue,*
and Antoine Gessain† |
|
|
|
 |
|
| Back to article | |
|
Figure 1. Representative seroreactivity pattern on Western blot that contains a recombinant GD 21 (common to human T-cell leukemia virus type 1 [HTLV-1] and HTLV-2) and 2 synthetic peptides specific for HTLV-1 (MTA-1) and HTLV-2 (K55). Lane 1, HTLV-1–positive control; lane 2, HTLV-2–positive control; lane 3, HTLV-1/2 negative control; lane 4–9, 6 plasma samples from the HTLV-1–positive women of Ambae Island displaying strong reactivity to GD 21 (faint band for VAN 251), to p19 and p24 (faint band for VAN 54), p26, p28, p32, p36 (faint bands for VAN 54 and AWM), and to MTA-1. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed March 30, 2005 |
|
|
Emerging
Infectious Diseases Journal |
|